Login to Your Account

Other News To Note

Wednesday, October 30, 2013

• Samsung Biologics, of Seoul, South Korea, and Roche AG, of Basel, Switzerland, said they entered a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea. Terms were not disclosed.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription